Teva

ZANOSAR

Manufacturer:

Teva

Zanosar HCPCS:

J9320

HCPCS Code Descriptor:

Injection, streptozocin, 1 gram

Category:

J Code

Zanosar NDCs:

00703-4636-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Zanosar:

ZANOSAR is an Oncology drug manufactured by Teva and administered via the Intravenous route of administration. The J Code: J9320 is aligned to the drug ZANOSAR.

ACCESS PRICING AND MORE BY REGISTERING

J9320 Added Date:

January 1, 1986

J9320 Effective Date:

January 1, 2009

J9320 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Zanosar billing and coding information.
Our team did not identify a source for Zanosar patient assistance information. Please reach out to our team if you feel that this is a mistake.
ZANOSAR prescribing information can be found at the link below:
Information regarding ZANOSAR’s side effects can be found at MedlinePlus